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ABSTRACT
The physiological functions of macrophage, which plays a central role in the 
pathogenesis of tuberculosis, depend on its redox state. System xc-, a cystine-
glutamate transporter, which consists of xCT and CD98, influences many ROS-
dependent pathways by regulating the production of the antioxidant glutathione. xCT's 
ability to alter this critical host redox balance by increasing the glutathione synthesis 
aspect of phagocyte physiology suggested that it might influence tuberculosis 
pathogenesis. In this study, we found that the xCT expression was increased in 
peripheral blood monocyte of active tuberculosis. xCT expression in macrophage 
was induced by Mycobacterium tuberculosis (Mtb) through TLR2/Akt- and p38-
dependent signaling pathway. Importantly, xCT deficiency conferred protection 
against tuberculosis, as xCT knock out mice displayed increased Mtb load and reduced 
pulmonary pathology in lung compared to wild type mice. xCT disruption enhanced the 
mycobateriacidal activity of macrophage through increasing the mycothiol oxidation. 
Importantly, chemical inhibition of xCT with sulfasalazine, a specific xCT inhibitor 
that is already approved by the FDA for treatment of inflammatory bowel disease, 
produces similar protective effects in vivo and in vitro, indicating xCT might be a novel 
and useful target for host-directed TB treatment strategy.
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INTRODUCTION
Tuberculosis (TB), a chronic bacterial disease 
caused by Mycobacterium tuberculosis (Mtb), remains a 
major global health problem that claims 1.4 million lives 
annually. However, only a relatively small proportion of 
Mtb-infected people develop active disease. The majority 
of immunocompetent individuals contain the pathogen and 
remain indefinitely asymptomatic, a status defined as latent 
tuberculosis infection (LTBI). Recent evidence suggests 
that inherited differences in the inflammatory profile of 
TB patients that associates primarily with ethnic variation 
in host, rather than bacillary genotype, plays a central role 
in TB disease [1, 2]. Understanding the mechanisms that 
dictate effective host defense against Mtb infection could 
suggest new strategies to elicit these protective responses 
in susceptible individuals.
Macrophage is the first line of host defense against 
Mtb, and the interaction between the bacterium and 
macrophage is crucial for determining the outcome of 
infection [3]. When appropriately activated, macrophages 
have the capacity to control the replication of intracellular 
Mtb through multiple mechanisms including the production 
of reactive oxygen species (ROS) and reactive nitrogen 
species (RNS), the induction of autophagy and apoptosis/
efferocytosis [4]. However, when the macrophage 
response is insufficient to control bacterial growth, this cell 
becomes a replication niche for the pathogen facilitating 
its replication and dissemination [3, 5]. Therefore, the 
mechanisms by which macrophage integrates activating 
signals and antimicrobial mechanisms during a protective 
immune response are central to protective immunity. 
The phagocyte antimicrobial response is complex and 
requires a variety of metabolic adaptations in addition to 
the simple induction of toxic compounds [6]. The oxidative 
burst is a clear example of the physiological complexity that 
accompanies antimicrobial immunity. Upon recognition 
of an invading microbe, such as Mtb, macrophage 
assembles an NADPH-oxidase that generates superoxide 
[7]. This radical is transformed both spontaneously and 
enzymatically into an array of toxic oxidative species, such 
as peroxide and hypochlorite. While these compounds are 
bactericidal, they also have detrimental effects on host 
cells. ROS can damage important cellular components, 
particularly essential iron-sulfur proteins [5]. To prevent 
the damage caused by ROS, macrophages utilize a 
cytosolic redox buffering system that consists largely of 
Glutathione (GSH) [8]. As a result, both the antimicrobial 
and immunoregulatory activities of the macrophage are 
likely to depend on an appropriate balance between ROS 
and GSH [5].
The glutamate/cystine antiporter system xc-, which 
transports cystine into cells in exchange for glutamate 
at a ratio of 1:1, is composed of a specific light chain, 
SLC7A11 or xCT and, and a heavy chain, 4F2 or CD98, 
linked by a disulfide bridge [9, 10]. Once transported 
into the cell, cystine is rapidly reduced into cysteine, the 
rate-limiting precursor of GSH. Consequently, induction 
of system Xc- has been recognized to be essential for 
oxidative stress resistance in a variety of cell types [11–13]. 
Considering the important role of xCT in regulating the 
phagocyte physiology, we hypothesized that xCT might 
associated with TB pathogenesis by tuning the function 
of macrophage. In this work, we found that recognition 
of Mtb infection by innate immune sensors induced xCT 
expression in macrophages. Disruption of xCT enhanced the 
antimicrobial activity of macrophages through diminishing 
GSH production. These effects were also evident in the 
murine model of TB that xCT deficiency simultaneously 
enhanced bacterial control and reduced the pathological 
neutrophil accumulation. Chemical modulation of xCT 
with SASP, an FDA-approved drug for inflammatory bowel 
disease (IBD), produces similar protective effects in vivo 
and in vitro, indicating xCT might be a novel and feasible 
target for TB treatment. 
RESULTS
Increased xCT expression is associated with 
active TB disease in humans
To investigate whether xCT is associated with the 
development of active TB disease, we first evaluated 
xct expression in peripheral blood mononuclear cells 
(PBMCs) from Healthy controls (HC), LTBI, and TB 
using qRT-PCR. We found that the level of xct mRNA was 
significantly increased in TB compared to HC and LTBI 
(Figure 1A). In consistence, xCT expression was found 
significantly higher in PBMCs from TB than those from 
HC at protein level (Figure 1B). In addition, we found that 
significantly higher percentages of xCT-expressing CD14+ 
monocytes in peripheral blood from TB patients compared 
to HC by flow cytometry (Figure 1C–1E). In line with 
previous report [14], neutrophils constitutively expressed 
high levels of xCT and lymphocytes did not express this 
protein (Figure 1C). However, we did not observe any 
difference in xCT expression in PMN from HC and TB 
(Figure 1E). Similarly, xCT was highly expressed in tissue 
macrophage within lung granuloma samples from TB 
(Figure 1F). Together, these results demonstrated that the 
expression of xCT on monocytes and macrophages was 
significantly increased in TB. 
Mtb induces xCT expression via a p38/AKT/
TLR2 pathway
To investigate the casual relationship between 
Mtb infection and increased xCT expression in TB, we 
examined the effect of Mtb infection on xCT expression 
in vivo and in vitro. As expected, xCT expression in 
the lung tissues was gradually increased in WT mice 
after Mtb (H37Rv) infection and the difference was 
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statistically significant at 30 days post infection (d30 
p.i.) (Supplementary Figure 1). Similar to the in vivo 
data, we found that Mtb infection significantly induced 
xct expression in U937 macrophages (Figure 2A). 
However, there was no difference of xCT expression 
observed between the virulent H37Rv and avirulent H37Ra 
strain, suggesting that induction of xCT expression was not 
attributed to the virulence (Figure 2A). In consistence, 
we found that heat-inactivated Mtb lysate as well as the 
19 kD lipoprotein derived from Mtb effectively induced 
xCT expression at least as efficiently as live Mtb (Figure 
2A). Since the 19 kD lipoprotein is a well-recognized potent 
Toll-like receptor 2 (TLR2) agonist [15, 16], the results 
above suggested that TLR2-signaling could be involved in 
xCT induction. As expected, blocking TLR2-signalling by 
monoclonal antibody against TLR2 resulted in more than 
50% decrease in Mtb-induced xCT expression (Figure 2B). 
On the other hand, the fact that blocking of TLR2 did not 
completely inhibit Mtb-induced xCT expression suggested 
that other pathways might participate. In line with previous 
reports, we found that the TLR4 ligand, lipopolysaccharide, 
also induced xCT expression (Figure 2A). Thus, we 
concluded that the increased xCT expression in TB was 
a direct effect of Mtb infection, mostly through activating 
TLR2 pathway.
Next, we further investigated the signaling pathway 
involved in Mtb-induced xct expression by quantification of 
xct expression in H37Ra infected U937 cells with or without 
PI3K inhibitor (LY294002), ERK inhibitor (U0126), JNK 
inhibitor (SP600125), p38 inhibitor (SB203580), or NFκB 
inhibitor (BAY11-7082). As shown in Figure 2C, inhibition 
of PI3K and p38 pathway, but not JNK and ERK pathway, 
significantly abolished the effect of Mtb in inducing xct 
expression at mRNA level, which was further confirmed 
by western blot analysis (Figure 2D). 
Genetic disruption of xCT renders mice resistant 
to TB with decreased lung bacterial burden and 
reduced pulmonary pathology
 To determine the potential role of xCT in the 
pathogenesis of TB, we compared outcomes of Mtb 
infection between wild type (WT) and xCT Knock out mice 
(xCT−/−) [9]. Compared to the WT mice, xCT−/− mice had a 
Figure 1: Increased xCT expression in active TB patients. (A) Expression of xct in peripheral blood samples from HC 
(n = 20), LTBI (n = 20), and TB (n = 20) was determined by qRT-PCR. Relative gene expression was normalized to GADPH. (B) xCT 
protein levels in PBMC from HC (n = 3) and TB (n = 3) were determined by immunoblotting. Bar graphs showing semi-quantification of 
xCT level relative to β-actin level, respectively. (C–E) Peripheral blood was stained with anti-CD3, CD14, CD16 and xCT antibody and 
analyzed by flow cytometry. (C) Histogram showed expression of xCT in different cell types from peripheral blood. (D) xCT expression 
on CD14+CD16− and CD14+CD16+ cells from active TB and HC. (E) The percentage of xCT expressing on CD14+CD16−, CD14+CD16+ 
and PMN cells from active TB (n = 10) and HC (n = 13). (F) Detection of xCT expression in infiltrated immune cells around tuberculous 
granuloma of lung tissue from patients with active tuberculosis by immunohistochemistry. The brown cells were the xCT positive cells. The 
one-way ANOVA Newman–Keuls Multiple Comparison Test was used for statistical analyses to compare the differences among multiple 
groups. Unpaired t-test was used to analyze the difference between two groups. *P < 0.05, **P < 0.01, ***P < 0.001.
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significant reduction in bacteria burden in the lung at d15 
and d30 p.i. (Figure 3A), indicating that disruption of xCT 
enhanced bacterial clearance. Additionally, the pathology 
was apparently reduced in the lung of xCT−/− mice at d30 
p.i., compared with WT mice (Figure 3B). Notably, WT 
mice developed large and many diffuse lesions that involved 
30–40% of the parenchyma, while the xCT−/− mice 
developed small granulomatous lesions occupying about 
10% of the lung parenchyma (Figure 3B). Histological 
examination revealed increased polymorphonuclear 
neutrophilic infiltration in the lung of the WT mice 
compared to the xCT−/− animals at d30 p.i. In consistence, 
the concentration of myeloperoxidase (MPO), a surrogate 
marker of PMN and inflammatory macrophages, was 
significantly higher in the lung tissue homogenates 
prepared from the WT mice than those from the xCT−/−mice 
at d30 p.i. (Figure 3C). Since chemokines and cytokines 
are critical to regulate inflammatory and immune responses, 
we therefore determined the expression of chemokines and 
cytokines in lung homogenates at d30 p.i. In line with the 
reduced neutrophils infiltration in the lung of xCT−/− mice, 
the expression of Cxcl2, Cxcl1 and Cxcr2 were significantly 
reduced in lung homogenates obtained from xCT−/− mice, 
compared to WT mice (Figure 3D). On the other hand, 
the expressions of cytokines (Ifn-γ, Tnf-α, Il-1β, Il-6, Il-10 
and Il-12) and other cytokines (Cxcl5 and Ccl2) were not 
different between xCT−/− and WT mice (Figure 3D). In 
corroboration with our clinical observation (Figure 1), these 
data indicated that xCT increases hosts susceptivity to TB.
Disruption of xCT has been reported to suppress 
differentiation and functions of dendritic cells [17], which 
may in turn inhibit Mtb-specific T cell responses. Since 
T cell responses are critical to protection against TB, we 
therefore determined if xCT alters adaptive immunity by 
monitoring cellular responses in the WT and xCT−/− mice 
after Mtb infection. We found that the frequencies of CD4, 
CD8 and CD19 cells did not differ significantly between the 
WT and xCT−/− mice in the mediastinal lymph nodes (MLN) 
Figure 2: Mtb induced xCT expression in macrophage. (A) xct expression in macrophages infected with H37Ra (MOI = 5), 
H37Rv (MOI = 5) or stimulated with Mtb lysates 10 μg/ml, 19 kD protein (1 μg/ml), LPS (100 ng/ml). (B) xCT expression in macrophage 
treated without or with anti-TLR2 mAb in the absence or presence of Mtb lysate stimulation for 24 hours. (C) qPCR detection of 
xCT in U937 macrophage infected with Mtb at MOI of 5 for 24 h in the presence of different kinase inhibitors, SB203580 (10 μM), 
SP600125 (10 μM), U0126 (10 μM), LY294002 (10 μM), BAY117082 (10 μM). (D) Western blot analysis of xCT expression in U937 
macrophage infected with Mtb at MOI of 5 for 24 h in the presence of different kinase inhibitors, SB203580 (10 μM), LY294002 (10 μM). 
(E) Western blot of the signaling pathways, p38 and Akt, in U937 macrophage infected with Mtb at MOI of 5 for indicated time. 
Representative data of 3 experiments were expressed as mean ± SEM *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001.
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or spleens (Figure 4A–4B). In addition, Mtb antigen–
specific CD4 and CD8 T cell responses, as measured by 
IFN-γ and IL-17 expression, were comparable in spleen 
from the WT and xCT−/− mice (Figure 4C). Similarly, there 
was no difference of IFN-γ- and IL-17- producing T cells 
in spleen upon stimulation with PMA/ionomycin (Figure 
4D). These data demonstrated that the T cell responses, at 
least those producing IFN-γ and IL-17, were intact in xCT−/− 
mice during Mtb infection, indicating that the resistance 
to TB conferred by xCT disruption is not associated with 
adaptive immune response. 
Chemical inhibition of xCT by SASP enhances 
mycobacterial clearance
Next, we took advantage of SASP, the chemical 
inhibitor specific for xCT, which had been widely used to 
disrupt xCT functions previously [18, 19], to determine if 
the beneficial effects of xCT deficiency could be translated 
into clinical application against TB. Mtb-infected mice 
were gavaged with SASP (20 mg/kg) starting on d21 p.i. 
and sacrificed on d42. Similar to xCT−/− mice, mice treated 
with SASP had significantly reduced bacterial load in the 
lung, spleen, lymph node and liver compared those treated 
Figure 3: Disruption of xCT renders mice resistant to TB. (A) Bacterial burden in the lungs of xCT−/− and WT (n = 4) mice assessed 
15–30 d after infection. (B) Histopathology of lungs from WT and xCT −/− mice infected with Mtb, stained with hematoxylin and eosin. 
Outlined areas in main images are enlarged in insets. The lung lopes of HE staining were photographed in digital form using NanoZoomer 
Digital Pathology System (Hamamatsu Photonics). The percentage of inflammation was determined as the ratio of inflammation area within 
the whole section of lung tissue area using Nanozoomer 2.0 software (Hamamatsu Photonics). Bar graphs show percentage of inflammation 
foci in lung from WT and xCT −/− mice. (C) The concentration of MPO in the lung homogenate from WT and xCT−/− 15 and 30 d after 
infection. (D) The relative expressions of cytokine and chemokine were determined using qRT-PCR in lung homogenates from WT and 
xCT −/− mice at 30 days after H37Rv infection. Representative data of 2 experiments were expressed as mean ± SEM *P ≤ 0.05, **P ≤ 0.01.
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with PBS (Figure 5A–5D). Histological examination 
revealed that SASP treatment reduced the lungs pathology 
with less apparent granulomas formation (Figure 5E). 
Considering the short-term use of SASP in our murine TB 
model and the advantage that FDA had already approved 
SASP for clinical use, these data indicated that modulating 
xCT is promising for potential clinical application. 
Disruption of xCT enhanced bacterial killing 
of macrophage through increasing bacterial 
mycothiol (MSH) oxidation 
To dissect the mechanisms underlying the beneficial 
effects of xCT disruption in TB, we investigated whether 
disruption of xCT directly inhibits bactericidal activity 
of macrophage. While xct deficiency had no effect on the 
capability of macrophage in uptaking Mtb (Supplementary 
Figure 2A), xct deficiency did significantly enhance 
the microbicidal activity of macrophage as the number 
of intracellular Mtb (both H37Ra and H37Rv) was 
significantly lower in macrophages from xCT–/– mice than 
those from the WT mice at d3 p.i. (Figure 6A). Notably, 
xct deficiency was phenocopied by application of specific 
xCT inhibitors, (S)-4-carboxyphenylglycine (4-CPG) [20] 
and SASP. At a concentration (200 nM) without decreasing 
cell viability (Supplementary Figure 2C–2F), both SASP 
and 4-CPG significantly enhanced the antimicrobial 
capacity of macrophage against H37Ra/H37Rv (Figure 6B, 
Supplementary Figure 2B). The enhancement of 
antimicrobial in macrophage by SASP was not due to 
5-ASA, a metabolic product of SASP, as the addition of 
SASP in xCT deficiency macrophage not further inhibit Mtb 
growth (data not shown).
Enhancement of autophagy and apoptosis in 
tumor cells have been reported as critical mechanisms 
underlying the anti-tumor effect of xCT disruption [18], 
we therefore evaluated whether apoptosis or autophagy 
is involved in enhancement of macrophage antimicrobial 
activity by disruption of xCT, two important mechanisms 
used by macrophage to kill Mtb [21, 22]. In line with 
previous reports [21, 22], we found that infection with 
Mtb significantly induced autophagy and apoptosis of 
macrophage (Supplementary Figure 2A–2D). However, 
disruption of xCT had a negligible effect on both events 
(Supplementary Figure 2A–2D), suggesting that the 
enhancement of macrophage bactericidal activity by xCT 
disruption was not due to altered autophagy and apoptosis. 
xCT maintains the redox status of the cell by 
promoting the synthesis of GSH, which scavenges 
intracellular ROS and NO [23]. We therefore investigated 
whether the enhancement of antimicrobial activity in xCT-
disrupted macrophages was due to altered GSH levels 
Figure 4: Disruption of xCT does not affect the adaptive immune response in mice infected with Mtb. At 30 d p.i., xCT−/− 
(n = 4) and WT (n = 4) mice were sacrificed, the mediastinal lymph node and spleen were collected from xCT−/− and WT mice. Single cell 
suspension was prepared and subjected for cell surface staining instantly, or cultured in the presence of PMA/ionomycin or Mtb-lysates for 
intracellular cytokines staining. The percentages of different cell subsets were determined by flow cytometry. (A) The percentages of CD4+, 
CD8+ and CD19+ cells within Mediastinal lymph node and (B) spleen from xCT−/− and WT mice were determined at 30 day post infection. 
The frequencies of IFN-γ- and IL-17-producing CD4 and CD8 T cells in spleen after short-term in vitro restimulation with Mtb lysate (C) 
or with PMA/ionomycin (D) were determined by flow cytometry. Representative data of 2 experiments were expressed as mean ± SEM 
*P ≤ 0.05, **P ≤ 0.01.
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and/or increased ROS and NO activity. As expected, the 
intracellular GSH levels in macrophages from the xCT−/− 
mice were significantly lower than those from the WT 
mice, either with or without H37Ra infection (Figure 6C). 
Similarly, disruption of xCT via SASP or 4-CPG 
significantly decreased GSH level in U937 macrophages 
upon H37Ra infection (Figure 6D). Moreover, addition of 
NAC, a precursor of GSH, reversed the enhancement of 
bactericidal activity by xCT disruption (Figure 6E–6F). 
Unexpectedly, we did not observe that any effect of xCT 
disruption on NO and ROS production by macrophages, 
despite the apparent effect on the production of GSH 
(Supplementary Figure 3A–3B). In consistence, addition 
of L-NAME, an inhibitor of NO synthase, did not change 
bactericidal activity in SASP or 4-CPG treated macrophage 
(Supplementary Figure 3C). Together, these data 
demonstrated that xCT disruption enhanced macrophage 
antimicrobial activity through diminishing GSH production, 
albeit no apparent effect on the production of NO and ROS 
was observed at cellular level.
While the data above indicated that disruption of xCT 
has no effect on ROS/NO production at cellular levels, the 
enhancement of bactericidal activity was clearly correlated 
with GSH level, through which a relative increase of ROS 
and/or ROS/GSH ratio could be expected. We therefore 
asked whether such a relative increase of ROS and/or 
ROS/GSH ratio might directly alter the oxidation state of 
intracellular bacteria [24]. Since the major cytosolic redox 
buffer of mycobacteria is the cysteine glycoconjugate, 
MSH, which is different from host GSH; the redox 
potential of the MSH pool can be specifically determined 
in situ using a ratiometric roGFP reporter fused to the 
specific MSH reductase Mrx1 [24]. By taking advantage 
of Mtb that was engineered to express the Mrx1-roGFP 
reporter, we determined the effect of xCT disruption on 
the oxidation state of intracellular mycobacteria. We found 
that disruption of xCT by SASP had no effect on the MSH 
redox state of H37Rv cultured in Middlebrook 7H9 Broth 
(Data not shown). In contrast, SASP significantly increased 
the oxidized MSH pool of H37Rv within infected 
macrophages at 48 h p.i. (Figure 6G–6H). Since high 
oxidation renders mycobacteria succumb to death [24], 
these data indicated that the increase of oxidative stress 
in intracellular mycobacteria was a critical mechanism for 
enhancement mycobateriacidal activity in xCT disruption 
macrophage.
DISCUSSION
Understanding the key regulatory mechanisms or 
molecules that dictate host resistance or susceptibility to 
Mtb infection is important for developing novel strategies 
for TB control. This is particularly important as MDR- and 
XDR- Mtb strains that are resistant to conventional anti-TB 
treatment become more common. Recently, several host 
molecules have been identified as potential host-directed 
therapy (HDT) targets [16, 25–27]. In this study, we found 
for the first time that xCT increases tuberculosis susceptibility 
by inhibiting antimicrobial function and inflammation and 
xCT might be a novel target for HDT against TB.
Clinically, increased xCT expression was associated 
with development of active TB. In mice, disruption of 
Figure 5: Disruption of xCT by SASP enhanced mycobacteria clearance in mice infected with Mtb. Mice infected with 
H37Rv were gavaged with SASP (20 mg/kg, n = 7) or PBS (n = 6) at d21 p.i. for another 21 days and then the mice were sacrificed. 
Bacterial burden in the lungs (A), spleens (B), MLNs (C) and livers (D) were assessed by plating of tissues homogenates and presented as 
Lg CFU. Mean ± SEM reported. *P ≤ 0.05. (E) Histopathology of lungs from mice infected with Mtb, stained with hematoxylin and eosin. 
Outlined areas in main images are enlarged in insets. The lung lopes of HE staining were photographed in digital form using NanoZoomer 
Digital Pathology System (Hamamatsu Photonics). Magnification, 40×. Experiments repeated at least twice, and mean ± SEM reported. 
*P ≤ 0.05, **P ≤ 0.01.
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xCT resulted in reduced bacterial load and pathology in 
the lung. Importantly, we found that disruption of xCT by 
pharmacological inhibitor, SASP, had similar effects as 
xct genetic deficiency. Therefore, our findings provided an 
important translational foundation for developing a novel 
host-direct therapy against TB. 
In line with KSHV infection, we found that xct 
deficiency or disruption of xCT by SASP enhanced 
intracellular mycobacteria killing activity in macrophage 
through diminishing GSH production. Replenishment of 
intracellular GSH levels by NAC, a precursor of GSH, 
abolished the enhanced killing activity of xCT-disrupted 
macrophages. However, unlike the case of KSHV infection, 
we found that the NO and ROS levels in xCT-disrupted 
macrophages upon infection with Mtb were comparable 
to those in WT macrophages. Nevertheless, the decrease 
of GSH resulted in altered ROS/GSH ratio, which was 
mirrored by the oxidation state of the mycobacterial MSH 
pool, suggesting that these redox buffers are directly or 
indirectly coupled. Consistently, we found that decrease in 
GSH levels in macrophage correlated with a more highly 
oxidized MSH pool in the intracellular mycobacteria. 
Several studies have found that intracellular bacterial 
pathogens can link their oxidation state to that of the host 
Figure 6: Disruption of xCT enhances macrophages to control mycobacterial infection. (A, C, E) Peritoneal macrophages 
from WT and xCT −/− mice were infected with Mtb at MOI of 5 in the absence or presence of NAC (500 μM). (B, D, F) U937 macrophages 
pretreated without or with SASP (200 μM), 4-CPG (100 μM) were infected with H37Ra at MOI of 5 in the absence or presence of NAC 
(500 μM). (A) CFUs in H37Ra or H37Rv infected macrophage lysates were enumerated at 3d after infection. (B) CFUs in H37Ra or H37Rv 
infected macrophage lysates were enumerated at 3d after infection. (C) The concentrations of intracellular GSH were evaluated by ELISA 
at 24 h after infection. (D) The concentrations of intracellular GSH were determined by ELISA at 24 h after infection. (E) CFUs in infected 
macrophage in the absence or presence of NAC (500 μM) were enumerated at 3 d after infection. (F) CFUs in infected macrophage in the 
absence or presence of NAC (500 μM) were enumerated at 3 d after infection. H37Ra survival rates were calculated by using mock or WT 
as a control. (G, H) Redox status of intracellular H37Rv population within macrophages. Immortalized C57BL/6 BMDM were infected 
with H37Rv that was engineered to express Mrx1-roGFP2, and ~30,000 cells were analyzed by flow cytometry by exciting at 405 and 
488 nm lasers at a constant emission (510 nm). (G) FACS dot plot of infected macrophages with Mrx1-roGFP2-expressing H37Rv in the 
absence of SASP and presence of SASP at 48 h p.i. (H) Bar graph represents percentage of oxidized subpopulation of Mtb during different 
time points post macrophage infection. Values represent the mean ± S.E. of duplicate determinations of experiments repeated twice. 
Statistical significance was calculated using unpaired student’s t test. Mean ± SD reported. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001.
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cell. For example, host glutathione can activate a critical 
virulence-associated transcription factor in the cytosol of 
L. monocytogenes [28] and F. tularensis acquires GSH 
from the host cell as a source of cysteine and to maintain 
its cytosolic redox buffer [29]. However, in the majority 
of these cases, the precise mechanism linking the redox 
buffering systems of these two cells remain unclear. In 
the case of F. tularensis, a GSH import system seems to 
be important. Interestingly, Mtb expresses an analogous 
dipeptide permease that contributes to the intracellular 
growth of Mtb [30, 31]. Thus, we hypothesize that host 
GSH is likely available to the bacterium as an alternative 
source of reducing potential to its endogenous mycothiol-
based buffering system.
The effect of NAC on macrophage mycobacterial 
killing is complex. We found that NAC abolished the 
enhancement of macrophage microbicidal activity conferred 
by xCT-disruption. Similarly, Roca et al reported that NAC 
abolished TNF-α induced ROS production and therefore 
reduced macrophage mycobacterial killing activity [5]. In 
contrast, enhancing GSH levels by NAC supplementation 
has also been shown to increase the BCG killing by 
macrophages or whole blood [32, 33]. Since these latter 
effects appeared to depend on NO production to form toxic 
S-nitrosoglutathione (GSNO) [32], the disparity the effect 
of NAC might result from the difference of NO production 
in these systems. Consistent with this model, both xCT 
disruption in this study and TNF-α in Roca et al report had 
no effect on modulating NO production [5]. 
With the purpose of translational medicine, we 
demonstrated that chemical modulation of xCT with 
SASP, a specific xCT inhibitor that was already approved 
by the FDA for use in humans, produces similar protective 
effects of xct deficiency in vivo and in vitro. SASP 
therapy significantly reduced the bacterial burden in the 
lung, draining lymph node, spleen, and liver in vivo. In 
consistence with the decreased bacterial burden, the 
histopathology was also reduced in the lung.  
In summary, we demonstrated that host xCT increases 
host susceptible to TB. Genetic disruption of xCT or 
chemical modulation of xCT with SASP significantly 
decreased the bactericidal burden and reduced histopathology 
in murine TB. By taking advantage of FDA approved use of 
SASP in human, our findings provided fundamental data for 
the potential clinical application of xCT as novel target for 
HDT against TB. 
MATERIALS AND METHODS
Ethics statement
The Research Ethics Committee of Shenzhen Third 
People’s Hospital approved the collection of peripheral blood 
exclusively for research purposes with the written informed 
consent of all participants (No. 2012–007). All mice 
experimental procedures were performed in accordance with 
the Regulations for the Administration of Affairs Concerning 
Experimental Animals approved by the State Council of 
People’s Republic of China. The animal experiments were 
approved by the Animal Research Ethics Committee of 
Shenzhen Third People’s Hospital (No. 2012–A003).
Subjects and clinical sample collection
Whole blood samples were collected from healthy 
controls (HC, n = 20), individuals with latent tuberculosis 
infection (LTBI, n = 20), and patients with active 
tuberculosis (TB, n = 20) at Shenzhen Third People’s 
Hospital. Diagnosis of active TB and LTBI was described 
previously [34]. Briefly, diagnosis of active TB was based 
on clinical symptoms, chest radiography, and microscopy 
for acid-fast bacilli (AFB), sputum Mtb culture, and 
response to anti-TB chemotherapy. A previously established 
Mtb specific interferon-gamma release assay (IGRA) was 
used to differentiate individuals with LTBI from healthy 
controls [35]. Detailed demographic characteristics are 
listed in Supplementary Table 1. All TB patients were 
positive for sputum Mtb culture. Whole blood was used for 
flow cytometry analysis or RT-PCR measurement of xCT 
expression. For western blot analysis, PBMCs were isolated 
from whole blood through density gradient centrifugation 
over Ficoll-Hypaque as described elsewhere [36]. 
Culture of cell lines and bacteria
Human leukemic monocyte lymphoma cell line U937 
cells (ATCC CRL 1593), were cultured in RPMI1640, 
supplemented with 10% fatal bovine serum (FBS), 
antibiotics (50 U/ml penicillin and 50 μg/ml streptomycin), 
0.1 mM non-essential amino acids and 1 mM sodium 
pyruvate in 5% CO2 at 37°C. U937 cells were pretreated 
with 20 ng/ml PMA for 24 h to differentiate them before 
infection with Mtb. Two mycobacterium strains, H37Ra 
and H37Rv were grown at 37°C in Middlebrook 7H9 broth 
(BD) with 0.05% Tween-80 and 10% oleic acid albumin-
dextrose-catalase (OADC) enrichment (BD). The inoculum 
was titrated by plating serial dilutions on Middlebrook 
7H11 medium plus 10% OADC. 
Murine TB model
C57BL/6 mice and xCT–/– mice (C57BL/6 
background) at 8–10 weeks old were used for Mtb 
infection. xCT–/– mice that had been backcrossed at least 
six times to C57BL/6 mice were provided by professor 
Shiro Bannai [37] and kept in Dr. Fudi Wang’s Lab. Mtb 
infection was performed with the virulent strain H37Rv. 
Mice were infected with H37Rv (~150 CFU) using a 
Glas-Col inhalation exposure system (Glas-Col, USA). 
At indicated time points, mice were sacrificed and the 
lungs were collected for bacterial burden enumeration, 
histopathology, and cytokines/chemokine measurements. 
Bacterial burdens were evaluated at different time points by 
homogenizing the lungs in PBS, and plating serial dilutions 
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onto Middlebrook 7H11 agar plates. After 3 weeks, Mtb 
colonies were counted. For drug treatment, mice were 
gavage administered SASP (20 mg/kg) or PBS every two 
days at d21 p.i. Mice were sacrificed at d 42 after infection. 
The lungs, spleens, lymph node, and livers were collected 
and CFUs were determined as described above. 
Flow cytometry
Fresh whole blood samples (200 μl each) from HC 
and TB patients were used for flow cytometry analysis 
of xCT expression. Briefly, erythrocytes were lysed with 
lysing solution (BD Biosciences) and then the samples 
were stained with surface mAbs against CD14 (BD 
Biosciences), HLA-DR (Immunotech), xCT (Thermo 
scientific) and CD16 (BD Biosciences). After incubating 
at room temperature for 15 min, the samples were stained 
with Alexa Fluor® 647 Goat Anti-Rabbit IgG Antibody 
(Invitrogen) for additional 15 min at room temperature. 
At least 0.2 million cells were acquired for analysis using 
FACSDiva software (BD Biosciences).
Lymph nodes and spleens from the Mtb-infected 
animals were used for flow cytometry experiments. Single 
cell suspensions were obtained from spleen and Lymph 
nodes by grinding the organ through a 70-µm strainer. 
Erythrocytes were removed with lysing solution (BD 
Biosciences), and the samples were surface stained with 
mAbs against CD3, CD19 and CD4 (BD Biosciences). For 
the intracellular staining of cytokines, spleen cells were 
stimulated with PMA (10 ng/ml, Sigma-Aldrich), ionomycin 
(1 m g/ml, Sigma-Aldrich) and brefeldin A (Sigma-Aldrich) 
for 6 h or with Mtb lysates for 24 h and incubated for the 
last 6 h with brefeldin A (10 mg/ml). Cells were stained with 
anti-CD4 and anti-CD3 in HBSS (containing 1% FBS), 
fixed with 2% formaldehyde, and permeabilized with 0.5% 
saponin. The cells were subsequently stained with anti-IL-17 
(eBioscience) and anti-IFNγ (eBioscience). Cells producing 
IFNγ and IL-17 were examined with flow cytometry.
RNA extraction and qRT-PCR
Whole blood samples collected from individuals 
classified as HC, LTBI and TB using PAXgene Blood 
RNA tubes (BD Biosciences). Total RNA was extracted 
using the PAXgene Blood RNA Kit (Qiagen) following 
the manufacturer’s instructions. For cell samples collected 
from cell culture and lung, total RNA was extracted 
using QIAamp RNA Mini Kit (Qiagen) following 
the manufacturer’s instructions. The RNA yield and 
A260/280 ratio were monitored with a NanoDrop ND1000 
spectrometer. Purified RNA was reverse transcribed to 
cDNA using PrimeScript®RT reagent Kit (TaKaRa). qPCR 
was performed using SYBR Green PCR Master Mix 
(TaKaRa) following the standard protocol. The relative 
mRNA expression of different genes was calculated by 
comparison with the housekeeping gene GAPDH using the 
2-ΔΔCt method [38], as described previously [34]. The primers 
used are listed in Supplementary Table 2.
Isolation of mouse macrophages
Peritoneal macrophages were isolated as described 
previously [39]. Briefly, C57BL/6 mice and xCT–/– mice 
were injected intraperitoneal with 2 ml of 3% thioglycollate 
medium (Sigma-Aldrich). After 3 days, cells were 
harvested by peritoneal lavage with cold PBS and allowed 
to adhere for 2 h. Non-adherent cells were removed by 
washing twice with PBS. The remaining adherent cells 
were cultured in DMEM (10% FBS) and used as primary 
peritoneal macrophages after at least 24 h. Bone marrow 
derived macrophage (BMDM) was obtained for WT 
C57BL/6 mice. Bone marrow cells from the tibia and femur 
were cultured in DMEM containing 10% FBS and 20 ng/ml 
recombinant mouse M-CSF. After 5 days, differentiated 
BMDMs were incubated in 10% FBS DMEM media.
Mycobacterial infection in macrophages
Peritoneal macrophages and differentiated U937 
cells were infected with H37Rv or H37Ra at an MOI of 5. 
After 4 h incubation, non-internalized bacteria were 
washed away with PBS and incubation with fresh complete 
medium. For CFU assays, cells were incubated for 0 and 
72 h in fresh complete DMEM. After incubation, cells were 
lysed with 0.1% SDS and cell lysates were diluted, plated 
on 7H11 Middlebrook agar plates, and incubated at 37°C 
in 5% CO2. CFU were counted 3–4 weeks later. For gene 
expression assay, cells were harvested at 24 after infection 
and subjected to RNA isolation or immunoblotting analysis. 
In some experiments, cells were pretreated with SASP, 
4-CPG (Bioying), NAC (Beyotime), anti-TLR2 (Novus 
Biologicals), LY294002, BAY117082, U1026, SB203590 
or SP600125 (Sellechchem) for 1 h. 
MPO assays
For MPO assays, the lungs were perfused with PBS, 
then the collected lung lobes were immediately dispersed 
in PBS supplemented with a protease inhibitor cocktail 
(Roche) and frozen at –20°C until analysis. Samples 
from lung homogenates were thawed and appropriately 
diluted. The concentration of MPO was evaluated using the 
MPO ELISA kit following the manufacturer’s instruction 
(USCNK).
Western blotting analysis
The cell pellet was lysed using a western lysis 
buffer (Beytime) supplemented with a cocktail of protease 
inhibitors (Sigma-Aldrich). The lysates were quantified and 
equivalent amounts of proteins were next separated by SDS-
PAGE on a 12% polyacrylamide gel and then transferred 
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onto a nitrocellulose membrane. The membranes were 
sequentially probed with the respective primary antibodies, 
followed by appropriate HRP-conjugated secondary 
antibodies (Abcam) and then visualized by exposure to 
X-ray film. Images were quantified by densitometry using 
Quantity One, version 4.5 software (Bio-Rad).
Redox status study
To study the redox state of mycothiolof mycobacteria 
ex vivo, Mtb (H37Rv strain) expressing Mrx1-roGFP2 was 
grown in Middlebrook 7H9 broth (Difco) supplemented 
with 10% OADC, 0.2% Glycerol and 0.1% Tween 80. 
Immortalized C57BL/6 BMDM seeded at 1 × 105 cells per 
well in 24-well plates treated with or without SASP were 
infected with Mrx1-roGFP2 expressing H37Rv at an MOI of 
10 and incubated for 1 h and 4 h respectively, at 37°C in 5% 
CO2. Extracellular bacteria were removed by washing twice 
with PBS. At different time points, infected macrophages 
were washed with PBS and treated with 10 mM NEM for 
5 min at 22°C followed by fixation with 4% PFA for 15 min 
at 22°C. After washing thrice with PBS, cells were scraped 
and analyzed using a MACSQuant Flow cytometer. The 
ratio of emission (510/10 nm) after excitation at 405 and 
488 nm was calculated. Data was analyzed using the FlowJo 
software.
Immunohistochemistry
Segments of lung tissue from mice or patient with 
active tuberculosis were fixed in 10% buffered formalin 
(Sigma-Aldrich) and embedded in paraffin. Histologic 
sections were stained with H&E for evaluation of 
pathology. Briefly, after hematoxylin and eosin staining, 
the whole microscope slide images were photographed 
in digital form using NanoZoomer Digital Pathology 
System (Hamamatsu Photonics). The percentage of 
inflammation was determined as the ratio of inflammation 
area within the whole section of lung tissue area using 
Nanozoomer 2.0 software (Hamamatsu Photonics) [40]. For 
immunohistochemistry, five micron-thick paraffin sections 
were collected on charged slides, deparaffinized, and re-
hydrated in water. After antigen retrieval in pH 6.0 citrate 
buffer for 5  min at 125 °C in a pressure cooker, sections 
were incubated with primary antibody against xCT for 2 h 
room temperature. Immunoreactions were revealed by 
a biotin-free dextran-chain detection system (Envision, 
DakoCytomation, Glostrup, Denmark) and were developed 
using 3′,3′-diaminobenzidine as the chromogen. 
GSH assays
Intracellular GSH concentration was determined by 
using a GSH-Glo™ Glutathione assay kit (Promega, USA) 
following the manufacturer’s instructions.
Statistical analysis
The one-way analysis of variance/ Newman-Keuls 
multiple comparison test was used for statistical analyses 
to compare the differences among multiple groups. The 
unpaired t test was used to analyze the difference between 
two groups. We used GraphPad Prism software (version 
5.0) for all the statistical analysis. Two-tailed statistical 
tests were conducted with a significance level of 0.05.
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